Adipen

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Adipen

Property Description
Active Ingredient Nifedipine
Form Oral Dosage Forms (Capsules, Tablets, Extended-Release)
Pharmacological Class Calcium Channel Blocker (CCB) / Dihydropyridine Derivative
Origin Synthetic Compound

Adipen is a prescription-only medication classified as a cardiovascular drug, clinically recognized for its role in facilitating blood flow and reducing strain on the heart and blood vessels. Its foundation is the synthetic compound Nifedipine, which is defined by its powerful vascular action within the pharmacological framework of high blood pressure and chest pain management. The brand Adipen is typically positioned for adult patient groups requiring consistent control over vascular tension.


Adipen: Identity and Pharmacological Classification

Adipen belongs to the Calcium Channel Blocker (CCB) pharmacological class, specifically identifying as a Dihydropyridine derivative. This classification indicates that the drug's therapeutic action is rooted in the inhibition of calcium moving into the smooth muscle cells of the arteries. As a single-active ingredient product, the entire therapeutic effect of Adipen stems from its core substance, Nifedipine, which acts predominantly on the vascular system. The primary benefit of this action is the achievement of reduced systemic vascular resistance, a physiological result crucial for increasing the efficiency of blood circulation and addressing symptoms related to high vascular pressure.


Composition and Available Oral Forms

The active substance, Nifedipine, is administered via the oral route and is available in multiple oral dosage forms optimized for different release profiles. These forms include standard capsules or immediate-release tablets, which provide rapid action, and extended-release tablets or sustained-release preparations. These are engineered using pharmaceutical excipients to deliver Nifedipine slowly and consistently over many hours. Nifedipine is utilized in managing high blood pressure and stable angina pectoris, serving a role in stabilizing the cardiovascular system. This distinction in delivery technology means patients managing chronic conditions often utilize the extended-release version to ensure uniform calcium influx inhibition throughout the day.

Regulatory References

  1. DailyMed

What side effects are possible with Adipen?

Possible Side Effects and Safety Information

Adipen is associated with a range of possible adverse reactions that affect multiple body systems, as documented in official government regulatory information. The most serious and clinically significant safety concerns relate to the cardiovascular and central nervous systems.

Serious and Clinically Significant Risks

Rare but serious adverse reactions involving the heart and lungs have been reported. These include Primary Pulmonary Hypertension (PPH), a progressive and often fatal lung disorder, and regurgitant valvular heart disease (heart valve problems).

Due to its classification as a Schedule IV controlled substance by the US Drug Enforcement Administration (DEA), Adipen carries a documented risk of psychological dependence and drug abuse. This potential for misuse is a key regulatory consideration for its short-term use.

Common Adverse Reactions

Adverse reactions that are frequently reported affect the Central Nervous System and Gastrointestinal System. These may include:

  • Central Nervous System (CNS) Effects: Insomnia, restlessness, overstimulation, dizziness, tremor, and headache.
  • Cardiovascular Effects: Palpitations (pounding or racing heartbeat), tachycardia (fast heart rate), and elevated blood pressure.
  • Gastrointestinal Effects: Dry mouth, unpleasant taste, diarrhea, or constipation.

Safety Limitations and Monitoring

Safety notes emphasize that Adipen is indicated only for short-term use. Prolonged continuous use may increase the risk of serious side effects, such as PPH. Patients with pre-existing cardiovascular disease (e.g., coronary artery disease, uncontrolled hypertension), hyperthyroidism, or glaucoma are generally restricted from using this medicine. Dosage adjustments for diabetes medications like insulin or oral hypoglycemic drugs may be necessary due to the drug's effects.

Overdose and Emergency Response

Overdose and When to Seek Help

An opioid overdose is an acute, life-threatening emergency that results from opioids overwhelming the part of the brain that regulates breathing, potentially leading to respiratory failure and death. The primary danger of an overdose is the profound slowing or cessation of breathing, requiring immediate intervention.

Signs of Opioid Overdose

Immediate emergency medical attention is required if a person shows any of the following signs, which are collectively known as the opioid overdose triad:

  • Unconsciousness: Inability to be awakened or speak, or extreme sleepiness.
  • Breathing Difficulties: Slowed, shallow, or stopped breathing, or making gurgling or snoring noises.
  • Pinpoint Pupils: Very small pupils (the black centers of the eyes) that do not react to light.

Other serious symptoms can include the body going limp, the face becoming pale and clammy, and the lips or fingernails turning blue or purple due to lack of oxygen.

Required Emergency Action

If an overdose is suspected, call 9-1-1 immediately and administer an opioid antagonist such as naloxone (if available) without delay. Naloxone rapidly reverses the effects of opioids and can restore normal breathing within minutes. Even if naloxone is administered, the person must be observed continuously until emergency medical services arrive, as the effects of the opioid may return.

Overdose risk is increased by taking excessive doses, using the medicine in a non-prescribed manner, or mixing opioids with other central nervous system depressants, such as alcohol or benzodiazepines.

Therapeutic Uses of Adipen

What Adipen Treats: Main Uses and Benefits

Adipen (Nifedipine) is a prescription cardiovascular medication used in situations involving certain distressing symptoms, primarily related to the regulation of blood flow and vascular tension. Its primary uses include the management of high blood pressure and the control of angina (chest pain).


The medication is commonly used across conditions presenting with acute episodes, including systemic arterial hypertension, chronic stable angina pectoris, vasospastic angina, and certain peripheral vasospastic disorders. In these scenarios, Adipen is commonly used to help with symptoms related to heightened physiological activity or symptoms that interfere with daily functioning.

“It is applied across domains where additional symptomatic support is needed to address symptom clusters of recurrent discomfort and tension.”

This provides a core therapeutic benefit that assists with maintaining functional stability. It also helps ease the overall symptom burden associated with symptoms related to systemic imbalance and symptoms that interfere with daily functioning. The medication is applied in scenarios where additional management of discomfort is required. It supports general well-being during symptomatic phases.


Quick Fact: Supportive Management for Symptoms That Interfere with Daily Functioning

Adipen is commonly used to help with symptoms related to heightened physiological activity, aiding in the management of episodic coldness and pain in the extremities and supporting general stability in blood pressure management.

Regulatory References

  1. Nifedipine: MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility: Who Can and Cannot Use Adipen (Nifedipine)

Official regulatory documents define strict criteria for the use of Adipen, focusing solely on population eligibility and non-eligibility.

Populations for Whom Use is Contraindicated

Adipen is strictly contraindicated for several groups based on acute health status or known sensitivities. Patients must not use this medicine if they have a known hypersensitivity to Nifedipine or other dihydropyridines. It is also prohibited for patients in cardiovascular shock, with unstable angina pectoris, or who have had a recent myocardial infarction. Furthermore, use is contraindicated with the concurrent administration of Rifampicin.

Age and Condition-Based Restrictions

Use in children and adolescents under 18 years is not recommended due to a lack of established safety and efficacy data. While use is permitted in older adults, treatment may require special consideration. The medicine is contraindicated during the first trimester of pregnancy and is not recommended for breastfeeding mothers. Patients with severe hepatic impairment or severe hypotension must be treated with caution.

What should I know about interactions with other medicines?

Adipen (phentermine) can interact with several other medications, substances, and products. Due to its stimulant properties, combining Adipen with other agents that raise blood pressure or heart rate can increase the risk of serious cardiovascular side effects, such as elevated blood pressure, rapid heart rate, or stroke.

Monoamine Oxidase Inhibitors (MAOIs)

Adipen must not be used during or within 14 days of taking an MAOI, including certain antidepressants and Parkinson’s medications. This combination carries a high risk of a hypertensive crisis (dangerously high blood pressure).

Other Key Drug Interactions

Drug Class / Examples Potential Interaction
Other Stimulants (e.g., certain ADHD drugs, decongestants) Increased risk of serious cardiovascular and nervous system side effects. Avoid use.
Antihypertensive Drugs (e.g., beta-blockers, ACE inhibitors) Adipen may decrease the blood pressure-lowering effects of these medications.
Serotonergic Drugs (e.g., SSRI and SNRI antidepressants) Increased risk of serotonin syndrome (a potentially life-threatening condition). Use together with caution and close monitoring.
Antidiabetic Agents (e.g., insulin, sulfonylureas) Weight loss with Adipen may improve blood sugar control, potentially requiring a dose adjustment for the diabetes medication to prevent hypoglycemia (low blood sugar).

Alcohol and Other Products

It is advisable to avoid alcohol while taking Adipen, as this combination can worsen side effects like dizziness, sedation, and difficulty concentrating. Excessive caffeine intake should also be monitored, as it may amplify the stimulant effects of the medication.

Mechanism of Action

Selective Blockade of Vascular Calcium Channels

The active ingredient acts as a selective inhibitor of L-type voltage-gated calcium channels ( Ca v1.2) located on the smooth muscle cells of the arteries. This interaction involves the inhibition of extracellular calcium ions ( Ca^2+) influx, a process essential for muscle contraction.


Disruption of Excitation-Contraction Coupling

By limiting the availability of intracellular calcium, the drug disrupts the crucial excitation-contraction coupling cascade that governs muscle tone. This interference prevents the activation of key regulatory enzymes, directly leading to the relaxation of arterial smooth muscle (vasodilation). This results in a subsequent decrease in the mechanical resistance present within the circulatory system, defined as systemic vascular resistance (SVR).


Constraint by Autonomic Feedback

The peripheral vasodilation caused by the primary mechanism can engage the body's autonomic homeostatic feedback loops via the baroreceptor reflex. This often leads to a compensatory increase in sympathetic outflow and a faster heart rate. This indirect physiological consequence modifies the mechanical reduction in SVR.

Dosage and Administration Information

How to Use Adipen

Adipen (Nifedipine) administration is dictated by the specific oral dosage form prescribed, which determines both the frequency and the physical handling requirements of the drug. The medication is exclusively administered via the oral route.


Dosing and Frequency Patterns

Administration patterns are categorized based on the release profile of the formulation:

  • Immediate-Release (IR) Formulations: These forms generally involve administration multiple times per day, typically three to four times daily, with doses ranging from 10 mg to 30 mg. The total daily dose is typically limited to a maximum of 180 mg.
  • Extended-Release (ER) Formulations: These forms are designed for consistent delivery and are administered once daily, with maintenance dose ranges typically between 30 mg and 90 mg.

Dosage initiation involves titration, where the starting dose is increased over 7 to 14 day intervals until the appropriate long-term maintenance level is reached.


Administration Specifics and Constraints

Extended-release tablets must be swallowed whole with a glass of water and must not be crushed, chewed, or divided under any circumstances. This restriction is necessary for maintaining the intended controlled-release mechanism. Administration timing for the ER tablet is typically independent of meals, although it is usually taken at the same time each day.

Dose adjustment is utilized for specific patient populations. For instance, the use of the lowest available starting dose is indicated for patients with hepatic impairment, and IR formulations are generally avoided for routine long-term use in older adults. If a dose is missed, the standard procedure is to skip the missed dose and take the next scheduled dose at the regular time, rather than doubling the dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Adipen

This overview summarizes the type of research that has been conducted on Adipen (Nifedipine) for its main uses, based on information reported by regulators and peer-reviewed scientific literature. The focus is on describing the study landscape, not providing clinical advice or treatment recommendations.


Evidence for Use in Systemic Arterial Hypertension (High Blood Pressure)

Research exploring Adipen's use for high blood pressure has utilized extensive Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews. These studies involved large populations of adults and were designed to monitor the measured outcomes related to changes in blood pressure and the monitoring outcomes related to major Cardiovascular Events like stroke or heart attack over years.

Studies reported measurements indicating patterns observed in the changes in blood pressure levels across patients in the studied groups. Longer-term observational cohorts and RCTs described patterns related to the incidence of cardiovascular events within the study groups. Findings were integrated into several large meta-analyses that described a coarse grading of High for the existing body of evidence structure.


Evidence for Use in Chronic Stable Angina Pectoris (Chest Pain)

The research exploring Adipen's use in chronic stable angina was evaluated through Randomized Controlled Trials and comparative studies involving adults with stable coronary artery disease. Research examined outcomes related to physical discomfort, monitoring the Frequency of Angina Episodes, the use of rescue medication, and Functional Measures such as the amount of time patients could exercise on a treadmill.

Trials consistently reported findings that help contextualize how patients reported their experience, documenting how measurements changed in the frequency of angina episodes and the duration patients could tolerate exercise. Research describes changes measured during the study period related to outcomes reflecting daily functioning or activity level.


The Landscape of Evidence Gaps and Uncertainty

Despite an extensive body of research for core indications, research highlights what is known—and what is still uncertain. A key limitation is that results apply only to the populations studied and do not reflect whether an individual will respond similarly.

The evidence quality varies across studies, particularly between the larger trials for high blood pressure and the smaller studies for the less common vasospastic conditions. Comparative evidence is lacking for certain modern treatment protocols, and the focus of many studies has been on short-term symptom changes rather than continuous monitoring of all possible health outcomes. Study results reflect the specific conditions under which they were conducted, providing context rather than individual predictions.

Key Studies & References Nifedipine: MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Adipen (FAQ)


Q: What is Adipen officially approved to treat?

A: Official regulatory documents indicate that the medicine is approved for the treatment of high blood pressure (hypertension). It is also approved for the control of chronic stable angina pectoris, which is a type of chest pain.


Q: What is the average length of time a person might take Adipen?

A: For its approved uses, such as managing high blood pressure and chronic stable angina, the medicine is generally indicated as a long-term treatment option. The specific duration of use is determined by the patient's healthcare provider based on their individual condition.


Q: Does Adipen require lifestyle changes like diet and exercise to work?

A: The effectiveness of the medicine itself is not dependent on specific lifestyle changes. However, official guidance for managing the underlying conditions it treats often includes recommendations for lifestyle modifications, such as diet and exercise.


Q: Does Adipen interact with common supplements like vitamins or herbal products?

A: Official warnings describe the need for caution when using certain herbal products alongside this medicine. Specifically, supplements such as St. John's wort and Ginkgo biloba have been noted to potentially affect how the medicine works in the body.


Q: Is there a list of specific foods or beverages that may interact with Adipen?

A: Official safety information includes a specific warning about consuming grapefruit juice and grapefruit-containing foods. These products are described as potentially causing increased levels of the medicine in the blood, which could alter the intended effect.


Q: Can Adipen affect the effectiveness of oral contraceptives?

A: Clinical studies have examined this potential interaction and indicate that the use of oral contraceptive steroids does not appear to influence the concentration of the unchanged active medicine in the blood plasma.


Q: How quickly can a person expect Adipen to start having an effect?

A: For the immediate-release capsule form, the medicine is reported to reach its maximum concentration in the blood plasma approximately 30 to 60 minutes after being taken. Extended-release forms are designed for a slower, more consistent action over time.


Q: What kind of monitoring or regular check-ups might be necessary while taking Adipen?

A: According to regulatory monographs, managing the underlying conditions treated by this medicine requires regular monitoring. This typically includes regular monitoring of blood pressure and other relevant cardiovascular parameters by a healthcare provider.


Q: Does taking Adipen require adjustments to the timing of other medications?

A: Official guidance on certain drug interactions specifies timing adjustments. For example, official guidance specifies that a 14-day time interval should be observed before taking the medicine if a patient has been using Monoamine Oxidase Inhibitors (MAOIs).


Q: What information should I have ready for my healthcare provider about other medications when discussing Adipen?

A: Official regulatory documents indicate that patients are typically instructed to discuss all current prescription and nonprescription medications with their healthcare provider. This includes any herbal products or supplements being taken to ensure there are no potential interactions.


Q: Is it common to feel nauseous when first starting Adipen?

A: Regulatory information documents that nausea is a commonly reported adverse reaction, which is a symptom affecting the digestive system. These kinds of effects often occur when first starting a medicine, but they are generally noted to lessen after the initial weeks of treatment.


Q: Is Adipen known to cause any long-term effects on the body?

A: Official safety documentation highlights that the medicine is generally indicated for short-term use for its initial labeled purpose. Taking the medicine continuously for long periods may be associated with an increased potential risk of certain serious adverse reactions, such as Primary Pulmonary Hypertension (PPH).


Q: Can Adipen affect mood or cause emotional changes?

A: Regulatory safety information indicates that the medicine can be associated with common adverse reactions affecting the central nervous system. These documented effects include mood changes and nervousness.


Q: Is there a maximum amount of time Adipen has been studied for continuous use?

A: Official guidance on the use of this medicine for chronic conditions, such as high blood pressure, describes it as being indicated for long-term treatment. However, regulatory documents for certain patient groups emphasize that prolonged use may increase risks, and such evidence is subject to ongoing evaluation by healthcare professionals.


Q: Are there common signs of a serious interaction or allergic reaction to Adipen?

A: Regulatory safety information describes signs of a serious allergic reaction. These can include swelling of the face, tongue, or throat, difficulty breathing, or a severe skin rash. These symptoms are often described as requiring prompt medical review.


Q: Do health official documents define a clear stopping point or 'exit strategy' for Adipen treatment?

A: Official guidance describes that the dose is typically gradually decreased by a healthcare provider rather than stopping suddenly. This is a common practice for medicines used to manage chronic cardiovascular conditions.


Q: Is it normal to feel tired or dizzy after taking Adipen?

A: According to official safety information, common adverse reactions affecting the nervous system include dizziness and a feeling of fatigue (tiredness). These effects are noted to sometimes lessen after the first few weeks of treatment.


Q: What should be done if a common side effect of Adipen does not go away?

A: If common side effects are bothersome or persist beyond the initial few weeks of starting the medicine, official patient safety resources describe that persistent or bothersome common side effects warrant a review by a healthcare provider.


Q: Does Adipen require a special diet, such as low-fat or low-sugar, to be effective?

A: The effectiveness of the medicine is not dependent on following a special low-fat or low-sugar diet. However, official guidelines for managing the chronic conditions it treats often include recommendations for dietary changes alongside the medication.


Q: Can Adipen cause issues with the gallbladder or pancreas?

A: Studies have described an inhibitory effect of the medicine on the contraction of the gallbladder. Pancreatic issues are not commonly listed as adverse reactions in primary regulatory safety summaries.


Q: Has Adipen been studied in different ethnic groups or populations?

A: Clinical guidelines for treating the conditions for which this medicine is used have sometimes incorporated population-specific considerations regarding the use of calcium channel blockers.


Q: Are the side effects of Adipen usually dose-dependent?

A: Pharmacological studies have described that the medicine's effect on certain physiological parameters, such as the depression of the calcium current, occurs in a dose-dependent manner.


Q: Can Adipen impact fertility in men or women?

A: According to regulatory-based information, no clear evidence suggests that taking the medicine reduces fertility in either men or women.


Q: Do I need to inform my dentist that I am taking Adipen?

A: The medicine is associated with adverse reactions that may affect the gums, such as swelling. Due to this potential effect, official guidance suggests this information be communicated to any medical or dental professional.

How should Adipen be stored and disposed of?

Storage and Disposal of Adipen (Nifedipine)

Adipen must be stored according to strict regulatory specifications to ensure stability, as Nifedipine is sensitive to environmental factors.

Official Storage Conditions

Requirement Specific Condition
Temperature Store at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F).
Protection Keep protected from light and moisture; keep away from excess heat and freezing.
Container Store in the original container and keep the container tightly closed.
Safety Keep the medication out of the sight and reach of children.

Disposal Instructions

Unused or expired Adipen should not be flushed down the toilet. Disposal must be completed through an official medicine take-back program or by consulting a pharmacist for guidance. If a take-back option is unavailable, the medication should be mixed with an undesirable substance and sealed before discarding in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Adipen found in:

A-Z Index: